PIPR THERAPEUTICS, INC.

Profile

Company Names

PIPR THERAPEUTICS, INC.
ARTIZAN BIOSCIENCES, INC.

Addresses

280 S. MANGUM ST., SUITE 350, DURHAM, NC 27701

150 MUNSON STREET, SUITE 210, NEW HAVEN, CT 06511

25 SCIENCE PARK, 150 MUNSON STREET, SUITE 210, NEW HAVEN, CT 06511

C/O HATTERAS VENTURE PARTNERS, 280 S. MANGUM STREET, SUITE 350, DURHAM, NC 27701

Phone Numbers

9193578326
203-785-6290

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$30,116,307.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-31 
$1,499,995.00 
$2,499,992.00 
$999,997.00 
Equity 
4
2020-12-21 
$18,877,921.00 
$18,877,921.00 
$0.00 
Equity 
3
2020-02-28 
$1,738,391.00 
$2,000,000.00 
$261,609.00 
Debt 
2
2019-03-04 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2016-09-29 
$3,000,000.00 
$5,000,000.00 
$2,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HEATHER 
 
MADSEN 
EXECUTIVE OFFICER, DIRECTOR
PIPR THERAPEUTICS, INC.
BRIDGET 
ANN 
MARTELL 
EXECUTIVE OFFICER, DIRECTOR
ARTIZAN BIOSCIENCES, INC.
DONNIE 
 
MCGRATH 
DIRECTOR
ARTIZAN BIOSCIENCES, INC.
ST. JOHN 
DONNIE 
MCGRATH 
DIRECTOR
ARTIZAN BIOSCIENCES, INC.
MARIAN 
 
NAKADA 
DIRECTOR
COSTIM PHARMACEUTICALS INC.   |  CALORICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  RIBON THERAPEUTICS, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  ALIADA THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.
JAMES 
H. 
ROSEN 
EXECUTIVE OFFICER, DIRECTOR
ARTIZAN BIOSCIENCES, INC.
CHRISTY 
 
SHAFFER 
DIRECTOR
CLINIPACE INC   |  EVOAPP, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  G1 THERAPEUTICS, INC.   |  KINODYN, INC.   |  SPYRYX BIOSCIENCES, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  GRAYBUG, INC.   |  TREFOIL THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  PERFUSE THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  AER THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
MONCEF 
 
SLAOUI 
DIRECTOR
SUTROVAX, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  ALTESA BIOSCIENCES, INC.   |  ZEPHYR AI, INC.   |  CUREVO, INC.
E. 
JONATHAN 
SODERSTROM 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  HISTORX INC   |  ARTIZAN BIOSCIENCES, INC.
JONATHAN 
 
SODERSTROM 
DIRECTOR
PHYTOCEUTICA, INC.   |  ARVINAS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  ARTIZAN BIOSCIENCES, INC.
CLAY 
 
THORP 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  CANCERGUIDE DIAGNOSTICS, INC.   |  PATHFINDER THERAPEUTICS, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  GENECENTRIC DIAGNOSTICS, INC.   |  G1 THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  ORIG3N, INC.   |  STRIDEBIO, INC.   |  GENECENTRIC THERAPEUTICS, INC.   |  VIGIL NEUROSCIENCE, INC.   |  PIPR THERAPEUTICS, INC.
HOLDEN 
 
THORP 
DIRECTOR
ARTIZAN BIOSCIENCES, INC.   |  PIPR THERAPEUTICS, INC.
WILLIAM 
 
WIESLER 
EXECUTIVE OFFICER, DIRECTOR
BIORELIX INC   |  ARTIZAN BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-31 
2022-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2020-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2020-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-28 
2019-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
2016-10-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#